Navigation Links
Vermillion Enhances Management Team With A Key Addition
Date:9/26/2011

ortfolio Management (Corporate) from 2004 to 2005, and Director, Research and Development (GIBCO™) from 2002 to 2003.  Dr. Munroe was Director of Technology Commercialization with Corning (Microarray Technologies) from 2000 to 2002, and has 10 years of pharmaceutical discovery research experience at R.W. Johnson Pharmaceutical Research Institute (1990 to 1995) and Allelix Biopharmaceuticals (1996 to 2000). Additionally, he has seven granted U.S. patents, and has authored peer-reviewed publications on the molecular basis of cancer, gastrointestinal disorders, inflammation and other topics.  

"The commercialization success of OVA1 and the solid foundation on which our OVA2 and peripheral artery disease (PAD) programs are based have given us the opportunity to expand our management team to meet both the commercialization and development requirements in order to drive stockholder value. In particular, we will proactively seek development partnerships that can leverage the value inherent in our OVA2 and PAD programs. Dr. Munroe's extensive industry experience will be invaluable in these initiatives. At the same time, we will be able to continue to grow OVA1 both domestically and internationally," said Gail S. Page, Chair and Chief Executive Officer of Vermillion, Inc.  

"I am very excited to join the executive management team at Vermillion," said Dr. Munroe. "With the introduction of OVA1, the first FDA-approved multi-analyte index for ovarian cancer, Vermillion has established itself as a leader in translating proteomic biomarker research into everyday medical practice.  I look forward to helping Gail and the team launch an exciting pipeline of IVDMIA diagnostics which today includes VASCLIR for PAD and OVA2, a next generation test for asymptomatic high-risk monitoring of ovarian cancer."

About Vermillion:

Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value dia
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vermillion Appoints Distribution Partner for OVA1® in Israel and the Palestine Territories
2. Vermillion Reports Financial Results for the First Quarter 2011
3. Vermillion Announces Presentation of Positive Ovarian Biomarker Data for Next Generation Test
4. Vermillion Attends 42nd Annual Meeting of the Society of Gynecologic Oncologists
5. Vermillion to Present at the Roth 23rd Annual OC Growth Stock Conference March 13-16, 2011, Laguna Niguel, CA
6. Vermillion Announces $21.8 Million Public Offering
7. Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Fourth Quarter 2010
8. Vermillion Announces Issuance of Patent for Peripheral Artery Disease
9. Vermillion Reappoints Three Directors, Approves a New Stock Incentive Plan, and Ratifies PricewaterhouseCoopers LLP as Its Accounting Firm
10. Vermillion Reports Financial Results for the Third Quarter 2010
11. Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Second Quarter 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)...  Now available for sale, The Armor1 Ankle Roll Guard is ... sprains by cushioning the ankle from an inversion or ... outside of any shoe type and allows the user ... protection against sprains. With customers in physical therapy, podiatry, ...
(Date:1/23/2015)... N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. ... its Phase I trial of Lixte,s lead compound, LB‑100, is ... John S. Kovach , M.D., the founder ... planned to be completed at a single site. Accrual of ...
(Date:1/23/2015)... Africa , Jan. 23, 2015   Leatt Corporation ... personal protective equipment for all forms of sports, including ... Leatt-Brace® neck brace, announced today that the UISP Lega ... now requires all riders to wear a neck brace ...
Breaking Medicine Technology:The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3
... 2010 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: ... fast-growing, profitable developer, manufacturer and seller of medicine and ... today that the Company will effect a two-for-one reverse ... minimum share price requirements in connection with its application ...
... 31, 2010 CVS Caremark (NYSE: CVS ... to acquire the Medicare Part D business of Universal ... billion.  Universal American is a leading Medicare Prescription Drug Plan ... acquisition will more than double the size of CVS ...
Cached Medicine Technology:Lotus Pharmaceuticals Announces Approval of Reverse Stock Split 2CVS CAREMARK to Purchase Universal American's Medicare Part D Business 2CVS CAREMARK to Purchase Universal American's Medicare Part D Business 3CVS CAREMARK to Purchase Universal American's Medicare Part D Business 4
(Date:1/22/2015)... Mass. (PRWEB) January 22, 2015 EBSCO ... (AMA) are expanding their relationship in an effort to ... around the world. While EBSCO has long made AMA journals ... a sales agent for The JAMA Network. , ...
(Date:1/22/2015)... a famous dress online store for wedding dresses and other ... of wedding dresses , and launches a site-wide women’s dress ... on your big day; the wedding gown is the most ... find the most suitable wedding dress. Now, we are proud ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Lower-Auto-Insurance.com has released a ... kit in a car for reducing the costs of an ... will also be able to get lower prices for their vehicle ... an important role in determining policy costs. Because of this, ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 State Forestry ... data management system with support from GEOSYSTEMS, a dedicated ... new solution will leverage Hexagon Geospatial’s ERDAS APOLLO ... data as well as point clouds and documents. This ...
(Date:12/26/2014)... said that nothing makes a lady feel more feminine than ... shows its new selection of navy cocktail dresses , ... navy cocktail gowns are the cornerstones of the site’s cocktail ... dresses in bright neon colors can be dressed up or ...
Breaking Medicine News(10 mins):Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2
... dengue fever that can sometime be deadly and this is ... ,Dengue fever is a benign acute febrile syndrome occurring in ... aegypti), transmitted viral disease. The virus causes Dengue shock syndrome ... as "serotypes") of dengue. , ,Infection and recovery from ...
... Stanford, CA -- Successful eradication of Helicobacter may not ... are left behind. This was reported by Research led ... of Medicine., ,The paper by Mueller et al., ... in the pathogenesis of Helicobacter-induced MALT lymphoma," appears in ...
... Wake Forest University School of Medicine had discovered a drug ... of sleep deprivation on the brain. The research results were ... of Science- Biology, and may go a long way in ... who work round the clock., ,The study’s results are ...
... research report, by researchers from National Institute of Child Health ... suggest that a drug used for reducing the risk of ... an alternative to conducting surgery after a miscarriage., ,The ... of Medicine. , ,The drug, misoprostol, has been used ...
... has entered the Guinness Book of Records after covering a ... in 28 hours. The 68-year-old Jan Klima's feat was announced ... Czech record database., ,The man from Trest, who ... walked to a regular check-up in Prague's Teaching Hospital. Klima ...
... processes between cells that could perhaps be extrapolated to prevent ... ,Normally cells have a blood supply to send nutrients from ... that don't have that, there has to be tiny bridge ... in the same way. This type of a communication network ...
Cached Medicine News:Health News:Dengue fever in Delhi after the Monsoon 2Health News:Dengue fever in Delhi after the Monsoon 3Health News:Dengue fever in Delhi after the Monsoon 4Health News:Helicobacter pylori Antibiotic Treatment of Peptic Ulcer May not Prevent Gastric lymphomas 2Health News:Treatment For Reversal Of Effects Of Sleep Deprivation In Brain 2Health News:Drugs As Alternative To Surgery After Miscarriage 2
The Link SP II Hip stem for cemented revisions...
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Quatroloc Revision Hip System...
Severe revision options for the knee and hip...
Medicine Products: